Banzai International Files 8-K on Financials
Ticker: BNZIW · Form: 8-K · Filed: Nov 19, 2024 · CIK: 1826011
Sentiment: neutral
Topics: financial-reporting, 8-K
Related Tickers: BNZI
TL;DR
Banzai Intl (BNZI) dropped an 8-K on Nov 19th covering financials. Check it out.
AI Summary
Banzai International, Inc. filed an 8-K on November 19, 2024, reporting on its results of operations and financial condition, and including financial statements and exhibits. The company, formerly known as 7GC & Co. Holdings Inc., is incorporated in Delaware and has its principal business address in Bainbridge Island, WA.
Why It Matters
This filing provides crucial updates on Banzai International's financial performance and condition, which is essential for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for financial reporting and does not indicate any immediate or significant risks.
Key Players & Entities
- Banzai International, Inc. (company) — Registrant
- 7GC & Co. Holdings Inc. (company) — Former company name
- November 19, 2024 (date) — Date of earliest event reported
FAQ
What specific financial information is being reported in this 8-K?
This 8-K reports on the 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was this 8-K filed?
The filing date for this 8-K is November 19, 2024.
What was Banzai International, Inc. previously named?
Banzai International, Inc. was formerly known as 7GC & Co. Holdings Inc.
In which state is Banzai International, Inc. incorporated?
Banzai International, Inc. is incorporated in Delaware.
What is the business address of Banzai International, Inc.?
The business address is 435 Ericksen Ave, Suite 308250, Bainbridge Island, WA 98110.
Filing Stats: 886 words · 4 min read · ~3 pages · Grade level 12.5 · Accepted 2024-11-19 16:30:34
Key Financial Figures
- $0.0001 — tered Class A common stock, par value $0.0001 per share BNZI The Nasdaq Capital M
- $11.50 B — A common stock at an exercise price of $11.50 BNZIW The Nasdaq Capital Market Indic
Filing Documents
- form8-k.htm (8-K) — 46KB
- ex99-1.htm (EX-99.1) — 76KB
- ex99-1_001.jpg (GRAPHIC) — 5KB
- 0001493152-24-046829.txt ( ) — 366KB
- bnzi-20241119.xsd (EX-101.SCH) — 4KB
- bnzi-20241119_def.xml (EX-101.DEF) — 30KB
- bnzi-20241119_lab.xml (EX-101.LAB) — 36KB
- bnzi-20241119_pre.xml (EX-101.PRE) — 27KB
- form8-k_htm.xml (XML) — 6KB
From the Filing
UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 19, 2024 Banzai International, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39826 85-3118980 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 435 Ericksen Ave , Suite 250 Bainbridge Island , Washington 98110 (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: (206) 414-1777 (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Class A common stock, par value $0.0001 per share BNZI The Nasdaq Capital Market Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 BNZIW The Nasdaq Capital Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 2.02 Results of Operations and Financial Condition. On November 14, 2024, Banzai International, Inc. (the "Company") held a conference call to discuss the Company's financial results for the three months ended September 30, 2024. A transcript of the call is furnished as Exhibit 99.1. The information reported under this Item 2.02 of Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. Neither this Current Report on Form 8-K, nor any exhibit attached hereto, is an offer to sell or the solicitation of an offer to buy the Securities described herein. Such disclosure does not constitute an offer to sell, or the solicitation of an offer to buy nor shall there be any sales of the Company's securities in any state in which such an offer, solicitation or sale would be unlawful. The securities mentioned herein have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United securities laws. This Form 8-K and the transcript furnished herewith may include statements that are "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements herein or in the exhibit hereto other than statements of historical fact are "forward-looking statements," which involve risks and uncertainties and are only predictions. Actual events or results may differ materially from those contemplated by forward-looking statements for a variety of reasons, including those described in the transcript furnished herewith. There are risks that the Company faces that could cause actual results to be materially different from those that may be set forth in forward-looking statements made by the Company. There also may be additional risks that the Company does not presently know or that it currently believes are immaterial which could also impair its business and results of operations. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Additional information regarding factors that could materially affect results and the accuracy of the forward-looking statements contai